Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial. - Fransecky L; Fiedler W; Röllig C; Sauer T; Raffel S; Alsdorf W; Heberling L; Steer B; Huber K; Versteegen T; Spory L; Deckbar D; et al. (Annals of hematology, 2026)